Vortioxetin (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vortioxetin" in Czech language version.

refsWebsite

Global rank Czech rank

5doi.org

2^nd place

4^th place

5nih.gov

4^th place

8^th place

3web.archive.org

1^st place

3fda.gov

447^th place

753^rd place

1drugs.com

399^th place

1,058^th place

1clincalc.com

3,912^th place

low place

1worldcat.org

5^th place

3^rd place

1firstwordpharma.com

low place

1europa.eu

68^th place

38^th place

clincalc.com

The Top 300 of 2021. clincalc.com [online]. [cit. 2024-06-12]. Dostupné online.

doi.org

dx.doi.org

CONNOLLY, KR; THASE, ME. Vortioxetine: a New Treatment for Major Depressive Disorder.. Expert Opinion on Pharmacotherapy. 2016, s. 421–31. DOI 10.1517/14656566.2016.1133588. PMID 26679430.
Köhler S, Cierpinsky K, Kronenberg G, Adli M. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants. J Psychopharmacol. 2016 Jan;30(1):13-22. DOI:10.1177/0269881115609072 PMID 26464458
KELLINY, Marc; CROARKIN, Paul E; MOORE, Katherine M. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Therapeutics and Clinical Risk Management. 2015-08-12, roč. 11, s. 1193–1212. PMID: 26316764 PMCID: PMC4542474. Dostupné online [cit. 2024-06-12]. ISSN 1176-6336. DOI 10.2147/TCRM.S55313. PMID 26316764.
Bang-Andersen B, Ruhland T, Jørgensen M, etal. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. Journal of Medicinal Chemistry. May 2011, s. 3206–21. DOI 10.1021/jm101459g. PMID 21486038.
SANCHEZ, C; ASIN, KE; ARTIGAS, F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol. Ther.. 2015, s. 43–57. DOI 10.1016/j.pharmthera.2014.07.001. PMID 25016186.

drugs.com

Vortioxetine Monograph for Professionals. Drugs.com [online]. [cit. 2024-06-12]. Dostupné online. (anglicky)

europa.eu

ema.europa.eu

EMA Brintellix page at EMA site Archivováno 26. 1. 2016 na Wayback Machine. Page accessed January 19, 2016

fda.gov

FDA approves new drug to treat major depressive disorder Archivováno 3. 10. 2013 na Wayback Machine., U.S. Food and Drug Administration Press Announcement.
Dostupné online.

accessdata.fda.gov

US Label Archivováno 31. 1. 2016 na Wayback Machine. Last updated July 2014 after review in September, 2014. Versions of label are available at FDA index page Page accessed January 19, 2016

firstwordpharma.com

FirstWord. firstwordpharma.com [online]. [cit. 2024-06-12]. Dostupné online. (anglicky)

nih.gov

ncbi.nlm.nih.gov

CONNOLLY, KR; THASE, ME. Vortioxetine: a New Treatment for Major Depressive Disorder.. Expert Opinion on Pharmacotherapy. 2016, s. 421–31. DOI 10.1517/14656566.2016.1133588. PMID 26679430.
Köhler S, Cierpinsky K, Kronenberg G, Adli M. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants. J Psychopharmacol. 2016 Jan;30(1):13-22. DOI:10.1177/0269881115609072 PMID 26464458
KELLINY, Marc; CROARKIN, Paul E; MOORE, Katherine M. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Therapeutics and Clinical Risk Management. 2015-08-12, roč. 11, s. 1193–1212. PMID: 26316764 PMCID: PMC4542474. Dostupné online [cit. 2024-06-12]. ISSN 1176-6336. DOI 10.2147/TCRM.S55313. PMID 26316764.
Bang-Andersen B, Ruhland T, Jørgensen M, etal. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. Journal of Medicinal Chemistry. May 2011, s. 3206–21. DOI 10.1021/jm101459g. PMID 21486038.
SANCHEZ, C; ASIN, KE; ARTIGAS, F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol. Ther.. 2015, s. 43–57. DOI 10.1016/j.pharmthera.2014.07.001. PMID 25016186.

web.archive.org

US Label Archivováno 31. 1. 2016 na Wayback Machine. Last updated July 2014 after review in September, 2014. Versions of label are available at FDA index page Page accessed January 19, 2016
FDA approves new drug to treat major depressive disorder Archivováno 3. 10. 2013 na Wayback Machine., U.S. Food and Drug Administration Press Announcement.
EMA Brintellix page at EMA site Archivováno 26. 1. 2016 na Wayback Machine. Page accessed January 19, 2016

worldcat.org

KELLINY, Marc; CROARKIN, Paul E; MOORE, Katherine M. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Therapeutics and Clinical Risk Management. 2015-08-12, roč. 11, s. 1193–1212. PMID: 26316764 PMCID: PMC4542474. Dostupné online [cit. 2024-06-12]. ISSN 1176-6336. DOI 10.2147/TCRM.S55313. PMID 26316764.